Shares of Healthequity Inc (NASDAQ:HQY) have been given a consensus recommendation of “Buy” by the fourteen research firms that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $86.70.
Several research analysts recently issued reports on HQY shares. Raymond James lifted their price objective on Healthequity from $80.00 to $85.00 and gave the stock an “outperform” rating in a research report on Monday. BidaskClub downgraded Healthequity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 30th. Zacks Investment Research upgraded Healthequity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 21st. Bank of America restated a “neutral” rating and set a $75.00 price objective (down from $83.00) on shares of Healthequity in a research report on Wednesday, June 5th. Finally, ValuEngine downgraded Healthequity from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $68.17, for a total value of $272,680.00. Following the completion of the sale, the vice president now directly owns 64,100 shares of the company’s stock, valued at approximately $4,369,697. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold a total of 12,000 shares of company stock valued at $876,200 over the last ninety days. 3.70% of the stock is owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in HQY. Signaturefd LLC grew its stake in shares of Healthequity by 24.3% during the 1st quarter. Signaturefd LLC now owns 803 shares of the company’s stock valued at $59,000 after buying an additional 157 shares during the period. Oregon Public Employees Retirement Fund grew its stake in shares of Healthequity by 0.9% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 21,721 shares of the company’s stock valued at $1,607,000 after buying an additional 190 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Healthequity by 5.9% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,953 shares of the company’s stock valued at $236,000 after buying an additional 220 shares during the period. Global Retirement Partners LLC grew its stake in shares of Healthequity by 72.7% during the 1st quarter. Global Retirement Partners LLC now owns 556 shares of the company’s stock valued at $41,000 after buying an additional 234 shares during the period. Finally, Diversified Trust Co grew its stake in shares of Healthequity by 1.5% during the 1st quarter. Diversified Trust Co now owns 16,340 shares of the company’s stock valued at $1,209,000 after buying an additional 247 shares during the period. 96.06% of the stock is owned by hedge funds and other institutional investors.
Shares of Healthequity stock traded down $1.59 during trading on Friday, hitting $69.95. 649,431 shares of the company were exchanged, compared to its average volume of 887,983. The company has a debt-to-equity ratio of 0.07, a current ratio of 15.60 and a quick ratio of 15.59. Healthequity has a fifty-two week low of $50.29 and a fifty-two week high of $101.58. The company has a market capitalization of $4.33 billion, a P/E ratio of 73.63, a P/E/G ratio of 2.73 and a beta of 1.56.
Healthequity (NASDAQ:HQY) last issued its quarterly earnings data on Monday, March 18th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.15 by $0.06. Healthequity had a return on equity of 14.17% and a net margin of 30.60%. The firm had revenue of $75.78 million during the quarter, compared to the consensus estimate of $74.28 million. During the same period in the previous year, the firm posted $0.09 EPS. The company’s quarterly revenue was up 25.4% compared to the same quarter last year. As a group, research analysts expect that Healthequity will post 1.01 EPS for the current fiscal year.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading: What is a Buy-Side Analyst?
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.